<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99099">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01857258</url>
  </required_header>
  <id_info>
    <org_study_id>2013H0116</org_study_id>
    <nct_id>NCT01857258</nct_id>
  </id_info>
  <brief_title>Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction</brief_title>
  <official_title>Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to formulate and validate a green tea confection (i.e.
      &quot;gummy&quot; candy) as a strategy to attenuate postprandial hyperglycemia-induced impairments in
      vascular function. The central hypothesis is that a green tea confection will protect
      against vascular endothelial dysfunction by suppressing postprandial hyperglycemia. The
      central hypothesis of this application will be assessed by developing a green tea-containing
      confection, examining its physiochemical properties and its inhibition of starch digestion,
      and then validating its vasoprotective activities in healthy humans by assessing its blood
      glucose-regulating activities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study involves validating a green tea confection (i.e. &quot;gummy&quot; candy) as a dietary
      strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function.
      The central hypothesis is that a green tea confection will protect against vascular
      endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of
      this application will be assessed by providing research participants 75 grams of
      carbohydrate in the form of a confection that contains no green tea concentrate or green tea
      concentrate at a level equivalent to approximately 3 cups of freshly brewed tea.  Blood
      glucose and brachial artery flow-mediated dilation will be assessed at regular intervals
      during the 3 hour postprandial period to define the extent to which green tea attenuates
      postprandial increases in blood glucose and decreases in vascular function that otherwise
      occur in a hyperglycemia-dependent manner.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Postprandial Glycemia</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood glucose will be measured at regular intervals throughout a 3 hour postprandial period following the ingestion of a confection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vascular Function</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Brachial artery flow-mediated dilation will be measured at regular intervals throughout a 3 hour postprandial period following the ingestion of a confection.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hyperglycemia</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Green Tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be provided a confection containing green tea concentrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be provided a confection devoid of green tea concentrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Green Tea Concentrate</intervention_name>
    <description>Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
    <arm_group_label>Green Tea</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Plasma glucose &lt;100 mg/dL

          -  Plasma total cholesterol &lt;200 mg/dL

          -  Plasma triglycerides &lt;140 mg/dL

          -  Blood pressure &lt;140/90

          -  non-dietary supplement user for &gt;2 months

          -  no use of medications known to affect carbohydrate metabolism,

          -  nonsmoker / never smoker

          -  no history of cardiovascular disease or gastrointestinal disorders

        Exclusion Criteria:

          -  allergies or aversions to green tea and/or corn starch,

          -  excessive alcohol consumption (&gt;3 drinks/d),

          -  &gt;5 h/wk of aerobic activity
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Bruno, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Bruno, PhD, RD</last_name>
    <phone>614-292-5522</phone>
    <email>bruno.27@osu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Bruno, PhD, RD</last_name>
      <phone>614-292-5522</phone>
      <email>bruno.27@osu.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Bruno, PhD, RD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 27, 2013</lastchanged_date>
  <firstreceived_date>May 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Richard Bruno</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>green tea</keyword>
  <keyword>catechins</keyword>
  <keyword>vascular endothelial function</keyword>
  <keyword>postprandial hyperglycemia</keyword>
  <keyword>oxidative stress</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
